# Event Summaries about HIV/AIDS

-  Pharmacy-Centered HIV Research: Current Landscape and Future Frontiers  June 28–29, 2023  Virtual  Researchers, pharmacists and pharmacy professionals, community members, and federal partners discussed how pharmacies are used to provide HIV testing, prevention, and care. 
-  Director’s Innovation Speaker Series: HIV-1 and SARS-CoV-2 Effects on Brain and Mind Health: A Tale of Two Viruses  November 9, 2022  Virtual  In a virtual fireside chat, Serena Spudich, M.D., M.A., and NIMH Director Joshua A. Gordon, M.D., Ph.D., will discuss the impact of HIV-1 and SARS-CoV-2 viruses on the central nervous system, similarities and differences in the pathology and clinical effects, and how this knowledge could inform research and interventions for SARS-CoV-2. 
-  Facebook Live: The Youth Mental Health Crisis  August 11, 2022  Virtual  As children prepare to return to school during these uncertain times, NIMH is conducting a Facebook Live event on the nation’s youth mental health crisis featuring Deputy Director Shelli Avenevoli, Ph.D. 
-  Macrophage Infection by HIV: Implications for Pathogenesis and Cure  October 13–14, 2021  NIMH and the Ragon Institute of MGH, MIT, and Harvard conducted a virtual meeting on the emerging data related to macrophage interactions with the immune system during HIV infection, macrophage reservoirs and approaches to their elimination, and the involvement of CNS myeloid reservoirs and associated co-morbidities. The meeting also highlighted recent work on macrophage inflammation in the context of SARS-CoV-2 infection and work from new NIMH-funded investigators. 
-  Neurologic and Psychiatric Effects of SARS-CoV-2 Meeting  July 14–15, 2021  Virtual  This meeting examined emerging data related to neurologic and psychiatric complications of SARS-CoV-2 infection and possible interactions with other infections such as HIV. 
-  Human Mobility and HIV Workshop  May 24–25, 2021  Prominent researchers share their perspectives on human mobility and its impact on HIV transmission, prevention, and care. 
-  Virtual Workshop: HIV-Related Intersectional Stigma Research Advances and Opportunities (HIVIS) Post-Workshop Deliverables  July 13–18, 2020  Webinar  On July 13, the National Institute of Mental Health held a virtual meeting to help promote HIV prevention and treatment science, as well as inform the Ending the HIV Epidemic initiative (EHE) and HIV efforts worldwide through furthering HIV-related intersectional stigma and discrimination research advances and opportunities. 
-  Strengthening the Research Workforce of Latina/Hispanic Female Investigators to Address HIV Contextual Factors Affecting Women with HIV   November 10, 2018  San Diego, CA; Pre-Conference Learning Institute at American Public Health Association Annual Meeting  The NIMH Division of AIDS Research hosted a meeting to address diversity mentoring programs to strengthen the HIV research workforce of Latina/Hispanic female investigators with added focus to address contextual factors affecting women living with HIV. 
-  Neuroimaging in HIV: Novel Imaging Technologies for Detection of Persistent HIV and Associated Inflammation/Pathology in the Brain  October 29, 2018  Rockville, MD  The NIMH Division of AIDS Research hosted a workshop to discuss the novel imaging technologies that can be used to detect persistent HIV in the central nervous system (CNS) as well as understand the pathways and mechanisms leading to CNS dysfunction in the antiretroviral therapy era. 
-  Anti-Retroviral Therapy-Mediated Mental Health Side Effects Workshop  September 12, 2018  Rockville, MD  This workshop covered the neuropsychiatric side effects of Antiretroviral Therapy (ART), and the potential for ART-mediated neurological toxicity when used across the lifespan of HIV. 
-  NeuroHIV in the ART era  October 23–24, 2017  Bethesda, MD  Despite the effectiveness of Anti-retroviral therapy (ART), HIV-induced CNS dysfunction persists, but a significant heterogeneity in the prevalence and severity of these disturbances still exist. Brain autopsy findings from HIV positive individuals on ART have revealed a paucity of the distinctive pathologic findings seen in the pre-ART era. 
-  Approach to Consortium Studies of CNS HIV Escape  October 11–14, 2017  Pollenzo, Italy  The NIMH Division of AIDS Research sponsored a session on “Approach to Consortium Studies of CNS HIV Escape” that was held in conjunction with the Seventh International Meeting on HIV infection in the CNS. 
-  Blood– brain barrier and HIV reservoirs in the CNS—formation and eradication  September 13–15, 2017  Krakow, Poland  The NIMH Division of AIDS Research hosted a session entitled “Blood– brain barrier and HIV reservoirs in the CNS—formation and eradication” in conjunction with the 20th International Symposium on Signal Transduction at the Blood–Brain Barriers. 
-  HIV PrEP Implementation Science Administrative Supplement Meeting  May 10, 2017  Bethesda, MD  The NIMH Division of AIDS Research sponsored a meeting to advance the science of HIV pre-exposure prophylaxis (PrEP) implementation. 
-  Innovative Measures of Medication Adherence for HIV Treatment and Prevention  March 13–14, 2017  Rockville, MD  The NIMH Division of AIDS Research co-sponsored a meeting with the National Institute of Allergy and Infectious Diseases (NIAID) to advance the next-generation of HIV medication adherence.  
-  Translating Mechanistic Stress Biology in the Context of HIV  November 7, 2016  Rockville, MD  The NIMH Division of AIDS Research sponsored a workshop to identify significant and unique courses of study aimed at elucidating the complex behavioral and biological relationships between stress and HIV. 
-  Global HIV-1 CSF Escape Consortium  June 9, 2016  Bethesda, MD  The NIMH Division of AIDS Research, with support from the NIH Office of AIDS Research, sponsored a meeting to establish a Global HIV-1 CSF Escape Consortium.  Despite stable and successful control of HIV with Antiretroviral Therapy (ART) in the periphery, some patients still have detectable HIV virus in the cerebrospinal fluid (CSF), termed “CSF escape.” Meeting participants discussed prevalence rates, causes, and key scientific research priorities pertaining to HIV-1 CSF escape.